The March 30, 2024 issue of The Economist includes a special section on Health and AI, with six articles on the topic. “Artificial intelligence (AI) is generating excitement and hyperbole everywhere, but in the field of health care it has the potential to be transformational,” said the lead article, “The AI doctor will see you … eventually.” “In Europe analysts predict that deploying AI could save hundreds of thousands of lives each year; in America, they say, it could also save money, shaving $200bn-360bn from overall annual medical spending, now $4.5trn a year (or 17% of GDP).”
Healthcare is a system of coupled systems, encompassing medical and pharmaceutical research; the delivery of healthcare to patients by a variety of practitioners, including hospitals, physicians, nurses, and pharmacists; and the insurance companies and governments that pay for healthcare. It’s a highly regulated industry, which creates major barriers for the sort of innovative start-ups that have been the engine of transformation in other sectors. In advanced economies, a handful of companies, — e.g., Cerner, Epic, Athena, — support large healthcare providers with proprietary platforms that don’t interoperate with each other, making it difficult for smaller companies and startups to develop innovative AI tools and applications as has been the case in other industries.
There’s considerable hope that AI could help us better deal with the inherent complexity of the healthcare sector. “AI systems can enhance diagnostic accuracy and disease tracking, improve the prediction of patients’ outcomes and suggest better treatments,” notes The Economist. “It can also boost efficiency in hospitals and surgeries by taking on tasks such as medical transcription and monitoring patients, and by streamlining administration. It may already be speeding the time it takes for new drugs to reach clinical trials. New tools, including generative AI, could supercharge these abilities.”
However, “although AI has been used in health care for many years, integration has been slow and the results have often been mediocre.” Among the major reasons for the slow progress are the concerns about accuracy and trust necessary to protect patients’ safety. “Improving accuracy and reducing bias in AI tools requires them to be trained on large data sets that reflect patients’ full diversity.” But, while there’s lots of available health data, the data is highly fragmented making it difficult to use properly.